Voyager Therapeutics (VYGR) Net Income Growth (3y) (2017 - 2026)
Voyager Therapeutics (VYGR) Net Income Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,019.86 Bn | 66,019.58 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 468.20 Bn | 463.41 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 122.50 Bn | 115.26 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 70.15 Bn | 61.39 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 55.58 Bn | 50.39 Bn | 1.41 Bn | 79.26% |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.43 Bn | 959.66 Mn | 47.10% |
| 10 | Voyager Therapeutics | 181.46 Mn | 39.98 Mn | - | -30.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.55% |
| Dec 31, 2025 | -5.12% |
| Sep 30, 2025 | -53.01% |
| Jun 30, 2025 | -20.48% |
| Mar 31, 2025 | -13.32% |
| Dec 31, 2024 | 30.64% |
| Sep 30, 2024 | 52.38% |
| Jun 30, 2024 | 38.08% |
| Mar 31, 2024 | 49.38% |
| Dec 31, 2023 | 36.28% |
| Sep 30, 2023 | -37.56% |
| Jun 30, 2023 | -4.42% |
| Mar 31, 2023 | 82.23% |
| Dec 31, 2022 | -23.37% |
| Sep 30, 2022 | 46.97% |
| Jun 30, 2022 | -54.83% |
| Mar 31, 2022 | 7.77% |
| Dec 31, 2021 | -65.36% |
| Sep 30, 2021 | -60.41% |
| Jun 30, 2021 | -18.70% |